1. Home
  2. MTG vs FOLD Comparison

MTG vs FOLD Comparison

Compare MTG & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MGIC Investment Corporation

MTG

MGIC Investment Corporation

HOLD

Current Price

$26.05

Market Cap

5.4B

Sector

Finance

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTG
FOLD
Founded
1957
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.5B
IPO Year
2008
2006

Fundamental Metrics

Financial Performance
Metric
MTG
FOLD
Price
$26.05
$14.49
Analyst Decision
Hold
Buy
Analyst Count
4
9
Target Price
$28.50
$27.25
AVG Volume (30 Days)
1.6M
2.5M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
2.06%
N/A
EPS Growth
8.65
50.00
EPS
0.76
N/A
Revenue
$1,213,636,000.00
N/A
Revenue This Year
$2.50
$20.50
Revenue Next Year
$1.77
$18.59
P/E Ratio
$33.96
N/A
Revenue Growth
0.49
N/A
52 Week Low
$24.69
$5.66
52 Week High
$29.97
$14.50

Technical Indicators

Market Signals
Indicator
MTG
FOLD
Relative Strength Index (RSI) 53.05 74.18
Support Level $25.57 $14.21
Resistance Level $27.14 N/A
Average True Range (ATR) 0.47 0.02
MACD 0.12 -0.00
Stochastic Oscillator 86.34 100.00

Price Performance

Historical Comparison
MTG
FOLD

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection account for close to the majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia, and New York.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: